Cas­sa­va CEO goes on the of­fen­sive over da­ta al­le­ga­tions, shout­ing down 'short at­tack'

Alzheimer’s play­er Cas­sa­va Sci­ences has been un­der fire in re­cent days af­ter a cit­i­zen pe­ti­tion with the FDA sug­gest­ed the com­pa­ny was play­ing fast and loose with its da­ta. Now, the com­pa­ny’s CEO is fight­ing back — but maybe not with the an­swers in­vestors are look­ing for.

In a lengthy pub­lic state­ment, Cas­sa­va CEO Re­mi Bar­bi­er blast­ed what he called a “short at­tack” on the com­pa­ny’s stock while do­ing lit­tle to di­rect­ly re­spond to a se­ries of al­le­ga­tions over da­ta ma­nip­u­la­tion out­lined in the cit­i­zen pe­ti­tion from last week.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER